337 related articles for article (PubMed ID: 24462657)
1. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients.
Abu Daya H; Alam MB; Adelstein E; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
Heart Rhythm; 2014 Apr; 11(4):614-9. PubMed ID: 24462657
[TBL] [Abstract][Full Text] [Related]
2. Effect of echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy on mortality and risk of defibrillator therapy for ventricular arrhythmias in heart failure patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] trial).
Adelstein E; Alam MB; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
Am J Cardiol; 2014 May; 113(9):1518-22. PubMed ID: 24630387
[TBL] [Abstract][Full Text] [Related]
3. Influence of QRS duration on outcome of death or appropriate defibrillator therapy by strategy of left ventricular lead placement in cardiac resynchronization therapy recipients.
Saba S; Marek J; Alam MB; Adelstein E; Schwartzman D; Jain S; Gorcsan J
J Interv Card Electrophysiol; 2014 Dec; 41(3):211-5. PubMed ID: 25391355
[TBL] [Abstract][Full Text] [Related]
4. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial.
Saba S; Marek J; Schwartzman D; Jain S; Adelstein E; White P; Oyenuga OA; Onishi T; Soman P; Gorcsan J
Circ Heart Fail; 2013 May; 6(3):427-34. PubMed ID: 23476053
[TBL] [Abstract][Full Text] [Related]
5. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
[TBL] [Abstract][Full Text] [Related]
6. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
[TBL] [Abstract][Full Text] [Related]
7. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study.
Muto C; Solimene F; Gallo P; Nastasi M; La Rosa C; Calvanese R; Iengo R; Canciello M; Sangiuolo R; Diemberger I; Ciardiello C; Tuccillo B
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):538-45. PubMed ID: 23592833
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of cardiac resynchronization therapy by the frequency of revascularization procedures in ischemic cardiomyopathy patients.
Husaini M; Biton Y; Stair B; Moss AJ; Biering-Sørensen T; Solomon S; McNitt S; Polonsky B; Zareba W; Barsheshet A; Kutyifa V
Cardiol J; 2016; 23(4):437-45. PubMed ID: 27320956
[TBL] [Abstract][Full Text] [Related]
9. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
[TBL] [Abstract][Full Text] [Related]
10. Optimal cut-off value of reverse remodeling to predict long-term outcome after cardiac resynchronization therapy in patients with ischemic cardiomyopathy.
Sugano A; Seo Y; Yamamoto M; Harimura Y; Machino-Ohtsuka T; Ishizu T; Aonuma K
J Cardiol; 2017 Feb; 69(2):456-461. PubMed ID: 26947101
[TBL] [Abstract][Full Text] [Related]
11. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
[TBL] [Abstract][Full Text] [Related]
12. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy.
Leyva F; Zegard A; Acquaye E; Gubran C; Taylor R; Foley PWX; Umar F; Patel K; Panting J; Marshall H; Qiu T
J Am Coll Cardiol; 2017 Sep; 70(10):1216-1227. PubMed ID: 28859784
[TBL] [Abstract][Full Text] [Related]
14. Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).
Buber J; Goldenberg I; Moss AJ; Wang PJ; McNitt S; Hall WJ; Eldar M; Barsheshet A; Shechter M
J Am Coll Cardiol; 2012 Aug; 60(8):749-55. PubMed ID: 22703927
[TBL] [Abstract][Full Text] [Related]
15. Multimodality imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
Sommer A; Kronborg MB; Nørgaard BL; Poulsen SH; Bouchelouche K; Böttcher M; Jensen HK; Jensen JM; Kristensen J; Gerdes C; Mortensen PT; Nielsen JC
Eur J Heart Fail; 2016 Nov; 18(11):1365-1374. PubMed ID: 27087019
[TBL] [Abstract][Full Text] [Related]
16. A metric for evaluating the cardiac response to resynchronization therapy.
Ge Y; Ruwald AC; Kutyifa V; McNitt S; Polonsky S; Klein H; Goldenberg I; Solomon SD; Foster E; Zareba W; Moss AJ
Am J Cardiol; 2014 Apr; 113(8):1371-7. PubMed ID: 24607029
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of echocardiographically guided left ventricular lead placement for cardiac resynchronization therapy in patients with intermediate QRS width and non-left bundle branch block morphology.
Marek JJ; Saba S; Onishi T; Ryo K; Schwartzman D; Adelstein EC; Gorcsan J
Am J Cardiol; 2014 Jan; 113(1):107-16. PubMed ID: 24169014
[TBL] [Abstract][Full Text] [Related]
18. The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy.
Doran B; Mei C; Varosy PD; Kao DP; Saxon LA; Feldman AM; DeMets D; Bristow MR
JACC Heart Fail; 2021 Jun; 9(6):439-449. PubMed ID: 33992570
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
[TBL] [Abstract][Full Text] [Related]
20. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
